Natera Cancer Test Infringes Invitae Patent, Suit Alleges
Invitae, a genetic testing company based in San Francisco, has launched a lawsuit in Delaware federal court claiming that a non-invasive cancer detection test produced by rival Natera infringes an Invitae-owned...To view the full article, register now.
Already a subscriber? Click here to view full article